SPP1 regulates alveolar type 2 cell-macrophage cross talk and epithelial cell fate in iron-driven lung fibrosis
American Journal of Physiology-Cell Physiology · 01.09.2025 · 329 (3) · C779-C800
DOI: 10.1152/ajpcell.00140.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.09.2025. Verfasst von Xinqian Du und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Alveolar Epithelial Cells, Pulmonary Fibrosis, Iron, Osteopontin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), | Natural Science Foundation of Beijing Municipality (), | Beijing Nova Program.
Abstract (Originalsprache)
This study reveals a novel mechanism linking iron dysregulation to pulmonary fibrosis through SPP1-mediated reprogramming of alveolar type 2 cells. We demonstrate SPP1’s dual role: externally coordinating macrophage recruitment and internally directing pathological epithelial transitions toward a Krt8 + intermediate state. These findings, validated across multiple mouse models and human specimens, identify the SPP1 signaling axis as a promising therapeutic target, offering new hope for treating this devastating condition where treatment options have historically been limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.
- Department of Clinical Laboratory, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, People's Republic of China.
- Immune Dysfunction and Pulmonary Fibrosis Joint Laboratory for Clinical Medicine, Capital Medical University, Beijing, People's Republic of China.
- Department of Respiratory Medicine, Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Ye Cui
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- | Natural Science Foundation of Beijing Municipality ()
- | Beijing Nova Program
- Shandong Laboratory Program
- 北京市科学技术委员会 | Natural Science Foundation of Beijing Municipality
- 北京市科学技术委员会 | Beijing Nova Program
Zitieren
APA
Du, X., Zhang, X., Wang, Z., Wang, D., Li, Y., Liu, Z., Miao, Q., Zhang, H., Duan, L., Hu, Y., Zhang, M., Liu, J., Lv, Z., Chen, Y., Wang, W., Sun, Y., & Cui, Y. (2025). SPP1 regulates alveolar type 2 cell-macrophage cross talk and epithelial cell fate in iron-driven lung fibrosis. American Journal of Physiology-Cell Physiology, 329(3), C779-C800. https://doi.org/10.1152/ajpcell.00140.2025
Vancouver
Du X, Zhang X, Wang Z, Wang D, Li Y, Liu Z, et al. SPP1 regulates alveolar type 2 cell-macrophage cross talk and epithelial cell fate in iron-driven lung fibrosis. American Journal of Physiology-Cell Physiology. 2025;329(3):C779-C800. doi:10.1152/ajpcell.00140.2025
BibTeX
@article{Du2025,
author = {Du, Xinqian and Zhang, Xinyu and Wang, Zhe and Wang, Dan and Li, Yunqi and Liu, Zengqing and Miao, Qing and Zhang, Hanxiao and Duan, Luo and Hu, Yue and Zhang, Muzhi and Liu, Jie and Lv, Zhe and Chen, Yan and Wang, Wei and Sun, Ying and Cui, Ye},
title = {SPP1 regulates alveolar type 2 cell-macrophage cross talk and epithelial cell fate in iron-driven lung fibrosis},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
volume = {329},
number = {3},
pages = {C779--C800},
doi = {10.1152/ajpcell.00140.2025}
}
EUVIMED